Webbprocainamide (English) retrieved. 3 October 2016. IEDB Epitope ID. 135397. 1 reference. stated in. Immune Epitope Database and Analysis Resource. IEDB Epitope ID. 135397. … WebbProcainamide (proe-KANE-a-mide) ( INN, trade names Pronestyl®, Procan®, Procanbid®) is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac …

Procainamide - WikEM

WebbMedia in category "Procainamide" The following 6 files are in this category, out of 6 total. 4-amino-N-(2-(diethylamino)ethyl)benzamide 200.svg 312 × 124; 9 KB. … WebbProcainamideis a medication of the antiarrhythmic classused for the treatment of cardiac arrhythmias. It is classified by the Vaughan Williams classificationsystem as class Ia; thus it is a sodium channel blockerof cardiomyocytes. In addition to blocking the INacurrent, it inhibits the IKrrectifier K+ current.[1] is tempeh soy free

procainamide C13H21N3O ChemSpider

WebbProcainamide has been reported to cause urticarial vasculitis, although it was not clear whether or not this was part of a lupus-like syndrome [43].A 70-year-old man developed a … Procainamide (PCA) is a medication of the antiarrhythmic class used for the treatment of cardiac arrhythmias. It is classified by the Vaughan Williams classification system as class Ia; thus it is a sodium channel blocker of cardiomyocytes. In addition to blocking the INa current, it inhibits … Visa mer Medical Procainamide is used for treating ventricular arrhythmias: ventricular ectopy and tachycardia and supraventricular arrhythmias: atrial fibrillation, and re-entrant and … Visa mer There are many side effects following the induction of procainamide. These adverse effects are ventricular dysrhythmia, bradycardia, hypotension and shock. The adverse effects … Visa mer 4-amino-N-2-(diethylamino)ethyl-benzamide (also known as para-amino-N-2-(diethylamino)ethyl-benzamide because the amino substituent is attached to the para-position, Arene substitution patterns of the benzene ring) is a synthetic organic compound with … Visa mer Mechanism of action Procainamide works as an anti-arrhythmic agent and is used to treat cardiac arrhythmia. … Visa mer Procainamide was approved by the US FDA on June 2, 1950, under the brand name "Pronestyl". It was launched by Bristol-Myers Squibb in 1951. Due to the loss of Indonesia in World War II, the source for cinchona alkaloids, a precursor of Visa mer WebbAntinuclear antibodies during procainamide treatment and drug acetylation. (English) 1 reference main subject antibody 1 reference author name string Davies DM series ordinal 1 1 reference Beedie MA series ordinal 2 1 reference Rawlins MD series ordinal 3 1 reference language of work or name English 0 references publication date 1 September 1975 if you win a lawsuit is it taxable